1. AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY. (2nd June 2020) Authors: Soldano, S.; Martinelli, G.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0185 Altered expression of relaxin receptor rxfp1/lgr7 in dermal fibroblasts contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis. (12th June 2018) Authors: Corallo, C.; Cutolo, M.; Soldano, S.; Cheleschi, S.; Fioravanti, A.; Pinto, A.M.; Renieri, A.; Nuti, R.; Giordano, N. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0199 Serum Levels, Tissue Expression and Cellular Secretion of Macrophage Migration Inhibitory Factor (MIF) in Limited and Diffuse Systemic Sclerosis. (9th June 2015) Authors: Corallo, C.; Cutolo, M.; Montella, A.; Chirico, C.; Magliocca, A.; Nuti, R.; Giordano, N. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0200 The Ineffectiveness of Relaxin Treatment to Ameliorate Dermal Fibrosis in Systemic Sclerosis Could be Due to Relaxin Receptor Alterations. (9th June 2015) Authors: Corallo, C.; Carrarelli, P.; Gianfrancesco, F.; Montella, A.; Chirico, C.; Magliocca, A.; Nuti, R.; Petraglia, F.; Giordano, N. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Collagen‐gelatin‐genipin‐hydroxyapatite composite scaffolds colonized by human primary osteoblasts are suitable for bone tissue engineering applications: In vitro evidences. Issue 5 (20th June 2013) Authors: Vozzi, G.; Corallo, C.; Carta, S.; Fortina, M.; Gattazzo, F.; Galletti, M.; Giordano, N. Journal: Journal of biomedical materials research Issue: Volume 102:Issue 5(2014:Jul.) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0399 Rnai-based identification of novel drug targets to reduce endothelial to mesenchymal transition (ENDOMT) in human dermal microvascular endothelial cells: a target discovery approach for scleroderma. (12th June 2018) Authors: Corallo, C.; Benschop, J.; Grimbergen, M.; Crawford, J.; Meuldijk, J.; Janssen, R.A.; Vandeghinste, N.E.; Giordano, N.; Tessari, M.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0423 Effects of selexipag in cultured scleroderma skin fibroblasts. (12th June 2018) Authors: Cutolo, M.; Ruaro, B.; Montagna, P.; Brizzolara, R.; Trombetta, A.C.; Scabini, S.; Tavilla, P.P.; Parodi, A.; Corallo, C.; Giordano, N.; Paolino, S.; Pizzorni, C.; Sulli, A.; Smith, V.; Soldano, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0293 EXOSOMES DERIVED FROM PLASMA OF SYSTEMIC SCLEROSIS (SSC) PATIENTS AND FROM SSC CULTURED FIBROBLASTS CONTAIN PRO-FIBROTIC MIRNA SIGNATURES AND COULD INDUCE MYOFIBROBLAST DIFFERENTIATION IN VITRO. (13th June 2020) Authors: Corallo, C.; Cutolo, M.; Soldano, S.; Selvi, E.; Bellisai, F.; Giordano, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0300 SERUM FROM "EARLY" SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES. (2nd June 2020) Authors: Soldano, S.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Pacini, G.; Goegan, F.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗